Journal article 821 views 328 downloads
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
Steve Bain 
,
Brian B. Hansen,
Samuel J. P. Malkin,
Solomon Nuhoho,
William J. Valentine,
Barrie Chubb,
Barnaby Hunt,
Matthew Capehorn
,
Brian B. Hansen,
Samuel J. P. Malkin,
Solomon Nuhoho,
William J. Valentine,
Barrie Chubb,
Barnaby Hunt,
Matthew Capehorn
Diabetes Therapy, Volume: 11, Issue: 1, Pages: 259 - 277
Swansea University Author:
Steve Bain
-
PDF | Version of Record
Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC).
Download (937.3KB)
DOI (Published version): 10.1007/s13300-019-00736-6
Abstract
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
| Published in: | Diabetes Therapy |
|---|---|
| ISSN: | 1869-6953 1869-6961 |
| Published: |
Springer Science and Business Media LLC
2020
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa52765 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Issue: |
1 |
| Start Page: |
259 |
| End Page: |
277 |